Regular BCR-ABL testing is key to managing CML. These tests measure the BCR-ABL protein level which will help you track your treatment progress. According to European LeukemiaNet (ELN) guidelines ...

The new accelerated approval covers the use of Scemblix for newly diagnosed patients with Philadelphia chromosome-positive CML in the chronic ... with the more stringent criteria of a deep ...